Ignite Creation Date:
2024-05-06 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 1:54 PM
Study NCT ID:
NCT04713709
Status:
COMPLETED
Last Update Posted:
2022-05-02
First Post:
2021-01-11
Brief Title:
A Single-Dose Bioequivalence Study of FMXIN001 4 mg Microspheres Powder
Sponsor:
Nasus Pharma
Organization:
Nasus Pharma
Organization Data
Organization:
Nasus Pharma
Class:
INDUSTRY
Study ID:
NP-NAL-004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nasus Pharma
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None